
What We're Reading: Pfizer Vaccine Timeline; Experts Warn of Third Wave; Millennial Mental Health Declines
Pfizer will not apply for emergency use authorization of its coronavirus disease 2019 (COVID-19) vaccine until at least mid-November; infectious disease experts warn of a potential third wave of COVID-19; rates of major depression increased among millennials.
Pfizer Says It Won’t Seek EUA for COVID-19 Vaccine Before Mid-November
This past Friday, Albert Bourla, PhD, CEO of Pfizer, said that the company would not apply for emergency use authorization (EUA) of its vaccine candidate against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), before the third week of November, which would rule out the possibility of a vaccine ready before Election Day on November 3.
Experts Warn of US’ Potentially Substantial Third Wave of COVID-19
According to
BCBSA Analysis Finds Millennials’ Mental Health on Decline
According to an analysis by the Blue Cross Blue Shield Association (BCBSA), a 12% increase was found in rates of major depression among a cohort of millennials from 2017 to 2018, with increased rates of alcohol use disorder (7%), tobacco use disorder (5%), and substance use disorder (5%) also noted within the time span. Reported by
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.